GNLX
Genelux Corporation
Price Chart
Latest Quote
$2.92
+0.00 (+0.00%)
Current Price
| Previous Close | $2.92 |
| Open | $2.87 |
| Day High | $2.97 |
| Day Low | $2.87 |
| Volume | 91,802 |
Stock Information
| Shares Outstanding | 44.84M |
| Total Debt | $2.50M |
| Cash Equivalents | $26.21M |
| Revenue | $8K |
| Net Income | $-33.58M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $130.93M |
| EPS (TTM) | $-0.85 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $105.95M |
| Sales | $8K |
| Income | $-33.58M |
| Book/sh | $0.52 |
| Cash/sh | $0.58 |
| Employees | 25 |
Financial Ratios
| Quick Ratio | 3.60 |
| Current Ratio | 3.68 |
| Debt/Eq | 10.88 |
Returns & Margins
| ROA | -60.56% |
| ROE | -127.28% |
| Gross Margin | 100.00% |
| Operating Margin | -432112.50% |
Ownership
| Insider Ownership | 13.76% |
| Institutional Ownership | 30.68% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -3.83 |
| P/S | 16366.75 |
| P/B | 5.66 |
Analyst Data
| Recommendation | none |
| Target Price | $17.50 |
Technical Indicators
| SMA20 | $2.97 |
| SMA50 | $2.85 |
| SMA200 | $3.72 |
| RSI | 48.44 |
| ATR | 0.1788 |
| Shares Float | 36.20M |
| Short Float | 7.21% |
| Short Ratio | 18.71 |
| Volatility | 0.55 |
| Rel Volume | 0.53 |
Performance History
| Week | -3.31% |
| Month | +0.00% |
| Quarter | +17.74% |
| 6 Months | -30.31% |
| YTD | -35.82% |
| Year | -1.68% |
| 3 Years | -91.93% |
| 10 Years | -52.52% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $2.92 | 91,800 |
| 2026-06-22 | $2.92 | 241,900 |
| 2026-06-18 | $2.96 | 98,800 |
| 2026-06-17 | $2.85 | 542,900 |
| 2026-06-16 | $3.03 | 158,500 |
| 2026-06-15 | $3.02 | 140,200 |
| 2026-06-12 | $2.96 | 116,800 |
| 2026-06-11 | $2.88 | 192,100 |
| 2026-06-10 | $2.86 | 174,100 |
| 2026-06-09 | $2.98 | 94,600 |
| 2026-06-08 | $2.93 | 80,700 |
| 2026-06-05 | $2.93 | 166,200 |
| 2026-06-04 | $3.08 | 138,600 |
| 2026-06-03 | $3.00 | 307,000 |
| 2026-06-02 | $2.95 | 142,700 |
| 2026-06-01 | $2.97 | 139,500 |
| 2026-05-29 | $3.05 | 114,700 |
| 2026-05-28 | $3.07 | 213,400 |
| 2026-05-27 | $3.06 | 216,300 |
| 2026-05-26 | $3.01 | 114,200 |
About Genelux Corporation
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec (olvimulogene nanivacirepvec), a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer. It also offers CHOICE, a technology and discovery and development platform; and developed an extensive library of isolated and engineered oncolytic VACV immunotherapeutic product candidates. The company has a licensing agreement with Newsoara BioPharma Co. Ltd. to research, develop, commercialize or exploit Olvi-Vec in China, including Mainland China, Taiwan, Hong Kong, and Macau, for human diagnostic, prophylactic, and therapeutic uses. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.
đ° Latest News
Institutions along with retail investors who hold considerable shares inGenelux Corporation (NASDAQ:GNLX) come under pressure; lose 16% of holdings value
Simply Wall St. âĸ 2025-11-20T10:35:53Z
Is Genelux (NASDAQ:GNLX) In A Good Position To Invest In Growth?
Simply Wall St. âĸ 2025-10-05T13:22:39Z
3 Promising Penny Stocks With Market Caps Under $200M
Simply Wall St. âĸ 2025-07-15T18:09:06Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $8,000 | $8,000 | $170,000 | $11,068,000 |
| Operating Revenue | $8,000 | $8,000 | $170,000 | $11,068,000 |
| Expenses | ||||
| Total Expenses | $33,222,000 | $31,704,000 | $24,335,000 | $14,081,000 |
| Net Non Operating Interest Income Expense | $1,069,000 | $1,457,000 | $-3,730,000 | $-1,408,000 |
| Operating Expense | $33,222,000 | $31,704,000 | $24,335,000 | $14,081,000 |
| General And Administrative Expense | $13,371,000 | $12,706,000 | $11,568,000 | $5,003,000 |
| Interest Expense | - | $0 | $822,000 | $1,408,000 |
| Other Income Expense | - | $370,000 | $-402,000 | $314,000 |
| Interest Expense Non Operating | - | $0 | $822,000 | $1,408,000 |
| Total Other Finance Cost | - | - | $3,152,000 | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-32,145,000 | $-29,869,000 | $-28,297,000 | $-5,207,000 |
| Net Interest Income | $1,069,000 | $1,457,000 | $-3,730,000 | $-1,408,000 |
| Interest Income | $1,069,000 | $1,457,000 | $244,000 | $0 |
| Normalized Income | $-32,145,000 | $-30,239,000 | $-27,895,000 | $-5,455,060 |
| Net Income From Continuing And Discontinued Operation | $-32,145,000 | $-29,869,000 | $-28,297,000 | $-5,207,000 |
| Total Operating Income As Reported | $-33,214,000 | $-31,696,000 | $-24,165,000 | $-3,013,000 |
| Net Income Common Stockholders | $-32,145,000 | $-29,869,000 | $-28,297,000 | $-5,207,000 |
| Net Income | $-32,145,000 | $-29,869,000 | $-28,297,000 | $-5,207,000 |
| Net Income Including Noncontrolling Interests | $-32,145,000 | $-29,869,000 | $-28,297,000 | $-5,207,000 |
| Net Income Continuous Operations | $-32,145,000 | $-29,869,000 | $-28,297,000 | $-5,207,000 |
| Pretax Income | $-32,145,000 | $-29,869,000 | $-28,297,000 | $-4,107,000 |
| Special Income Charges | $0 | $370,000 | $-402,000 | $314,000 |
| Interest Income Non Operating | $1,069,000 | $1,457,000 | $244,000 | $0 |
| Operating Income | $-33,214,000 | $-31,696,000 | $-24,165,000 | $-3,013,000 |
| Per Share | ||||
| Diluted EPS | $-0.86 | $-0.95 | $-1.16 | $-0.22 |
| Basic EPS | $-0.86 | $-0.95 | $-1.16 | $-0.22 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $65,940 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-32,640,000 | $-31,163,000 | $-26,055,000 | $-2,045,000 |
| Total Unusual Items | $0 | $370,000 | $-402,000 | $314,000 |
| Total Unusual Items Excluding Goodwill | $0 | $370,000 | $-402,000 | $314,000 |
| Reconciled Depreciation | $574,000 | $903,000 | $1,018,000 | $968,000 |
| EBITDA (Bullshit earnings) | $-32,640,000 | $-30,793,000 | $-26,457,000 | $-1,731,000 |
| EBIT | $-33,214,000 | $-31,696,000 | $-27,475,000 | $-2,699,000 |
| Diluted Average Shares | $37,176,527 | $31,450,727 | $24,429,278 | $23,647,442 |
| Basic Average Shares | $37,176,527 | $31,450,727 | $24,429,278 | $23,647,442 |
| Diluted NI Availto Com Stockholders | $-32,145,000 | $-29,869,000 | $-28,297,000 | $-5,207,000 |
| Research And Development | $19,851,000 | $18,998,000 | $12,767,000 | $9,078,000 |
| Selling General And Administration | $13,371,000 | $12,706,000 | $11,568,000 | $5,003,000 |
| Other Gand A | $4,009,000 | $4,011,000 | $3,718,000 | $1,102,000 |
| Insurance And Claims | $870,000 | $966,000 | $1,078,000 | $334,000 |
| Salaries And Wages | $8,492,000 | $7,729,000 | $6,772,000 | $3,567,000 |
| Other Special Charges | - | $-370,000 | $402,000 | $-314,000 |
| Tax Provision | - | - | $0 | $1,100,000 |
Fetched: 2026-06-13
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $11,544,000 | $26,274,000 | $19,473,000 | $-35,783,000 |
| Total Assets | $19,027,000 | $34,716,000 | $27,893,000 | $5,531,000 |
| Total Non Current Assets | $3,897,000 | $3,168,000 | $3,690,000 | $3,639,000 |
| Other Non Current Assets | $144,000 | $92,000 | $92,000 | $92,000 |
| Current Assets | $15,130,000 | $31,548,000 | $24,203,000 | $1,892,000 |
| Other Current Assets | $535,000 | $653,000 | $1,012,000 | $1,495,000 |
| Cash Cash Equivalents And Short Term Investments | $14,595,000 | $30,895,000 | $23,191,000 | $397,000 |
| Cash And Cash Equivalents | $5,333,000 | $8,565,000 | $9,418,000 | $397,000 |
| Cash Equivalents | - | $7,578,000 | $7,924,000 | - |
| Cash Financial | - | $987,000 | $1,494,000 | $397,000 |
| Non Current Deferred Assets | - | - | $0 | $1,568,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $1,685,000 | $1,868,000 | $2,519,000 | $26,353,000 |
| Long Term Debt And Capital Lease Obligation | $1,258,000 | $1,539,000 | $1,866,000 | $9,688,000 |
| Current Debt And Capital Lease Obligation | $427,000 | $329,000 | $653,000 | $16,665,000 |
| Net Debt | - | - | - | $24,526,000 |
| Long Term Debt | - | - | - | $8,524,000 |
| Current Debt | - | - | - | $16,399,000 |
| Other Current Borrowings | - | - | - | $15,407,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $7,483,000 | $8,442,000 | $8,420,000 | $41,314,000 |
| Total Non Current Liabilities Net Minority Interest | $1,258,000 | $1,539,000 | $1,866,000 | $9,688,000 |
| Current Liabilities | $6,225,000 | $6,903,000 | $6,554,000 | $31,626,000 |
| Payables And Accrued Expenses | $4,358,000 | $5,570,000 | $3,784,000 | $11,770,000 |
| Payables | $4,358,000 | $5,570,000 | $3,784,000 | $6,775,000 |
| Accounts Payable | $4,358,000 | $5,570,000 | $3,784,000 | $6,775,000 |
| Current Deferred Liabilities | - | - | $0 | $170,000 |
| Current Notes Payable | - | - | $0 | $992,000 |
| Interest Payable | - | - | $0 | $4,995,000 |
| Other Current Liabilities | - | - | - | $169,000 |
| Equity | ||||
| Common Stock Equity | $11,544,000 | $26,274,000 | $19,473,000 | $-35,805,000 |
| Total Equity Gross Minority Interest | $11,544,000 | $26,274,000 | $19,473,000 | $-35,783,000 |
| Stockholders Equity | $11,544,000 | $26,274,000 | $19,473,000 | $-35,783,000 |
| Gains Losses Not Affecting Retained Earnings | $9,000 | $64,000 | $14,000 | $2,000 |
| Other Equity Adjustments | $9,000 | $64,000 | $14,000 | $2,000 |
| Retained Earnings | $-283,538,000 | $-251,393,000 | $-221,524,000 | $-189,784,000 |
| Preferred Stock Equity | - | - | - | $22,000 |
| Other | ||||
| Treasury Shares Number | $433,333 | $433,333 | $433,333 | - |
| Ordinary Shares Number | $38,139,144 | $34,728,140 | $26,788,986 | $23,569,841 |
| Share Issued | $38,572,477 | $35,161,473 | $27,222,319 | $23,569,841 |
| Tangible Book Value | $11,544,000 | $26,274,000 | $19,473,000 | $-35,805,000 |
| Invested Capital | $11,544,000 | $26,274,000 | $19,473,000 | $-10,882,000 |
| Working Capital | $8,905,000 | $24,645,000 | $17,649,000 | $-29,734,000 |
| Capital Lease Obligations | $1,685,000 | $1,868,000 | $2,519,000 | $1,430,000 |
| Total Capitalization | $11,544,000 | $26,274,000 | $19,473,000 | $-27,259,000 |
| Treasury Stock | $433,000 | $433,000 | $433,000 | $433,000 |
| Additional Paid In Capital | $295,468,000 | $278,001,000 | $241,389,000 | $154,401,000 |
| Capital Stock | $38,000 | $35,000 | $27,000 | $31,000 |
| Common Stock | $38,000 | $35,000 | $27,000 | $9,000 |
| Long Term Capital Lease Obligation | $1,258,000 | $1,539,000 | $1,866,000 | $1,164,000 |
| Current Capital Lease Obligation | $427,000 | $329,000 | $653,000 | $266,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,440,000 | $1,004,000 | $2,117,000 | $2,852,000 |
| Current Accrued Expenses | $1,440,000 | $1,004,000 | $2,117,000 | $4,995,000 |
| Net PPE | $3,753,000 | $3,076,000 | $3,598,000 | $1,979,000 |
| Accumulated Depreciation | $-3,927,000 | $-3,684,000 | $-3,449,000 | $-2,950,000 |
| Gross PPE | $7,680,000 | $6,760,000 | $7,047,000 | $4,929,000 |
| Leases | $557,000 | $557,000 | $557,000 | $557,000 |
| Construction In Progress | $2,347,000 | $1,299,000 | $995,000 | $0 |
| Other Properties | $4,501,000 | $4,629,000 | $5,220,000 | $4,097,000 |
| Machinery Furniture Equipment | $275,000 | $275,000 | $275,000 | $275,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $9,262,000 | $22,330,000 | $13,773,000 | $0 |
| Preferred Stock | - | $0 | $0 | $22,000 |
| Current Deferred Revenue | - | - | $0 | $170,000 |
Fetched: 2026-06-13
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-26,366,000 | $-21,609,000 | $-21,300,000 | $-3,620,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-25,268,000 | $-21,228,000 | $-20,275,000 | $-3,571,000 |
| Cash Flow From Continuing Operating Activities | $-25,268,000 | $-21,228,000 | $-20,275,000 | $-3,571,000 |
| Operating Gains Losses | - | - | $3,554,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-1,098,000 | $-381,000 | $-1,025,000 | $-49,000 |
| Investing Cash Flow | $12,141,000 | $-8,131,000 | $-14,724,000 | $-49,000 |
| Cash Flow From Continuing Investing Activities | $12,141,000 | $-8,131,000 | $-14,724,000 | $-49,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $9,657,000 | $27,818,000 | $39,645,000 | $0 |
| Financing Cash Flow | $9,895,000 | $28,506,000 | $44,020,000 | $-478,000 |
| Cash Flow From Continuing Financing Activities | $9,895,000 | $28,506,000 | $44,020,000 | $-478,000 |
| Net Common Stock Issuance | $9,657,000 | $27,818,000 | $39,645,000 | $0 |
| Common Stock Issuance | $9,657,000 | $27,818,000 | $39,645,000 | $0 |
| Net Other Financing Charges | - | - | $-303,000 | $-1,568,000 |
| Other | ||||
| End Cash Position | $5,333,000 | $8,565,000 | $9,418,000 | $397,000 |
| Beginning Cash Position | $8,565,000 | $9,418,000 | $397,000 | $4,495,000 |
| Changes In Cash | $-3,232,000 | $-853,000 | $9,021,000 | $-4,098,000 |
| Proceeds From Stock Option Exercised | $238,000 | $688,000 | $4,463,000 | $120,000 |
| Net Investment Purchase And Sale | $13,239,000 | $-7,750,000 | $-13,699,000 | $0 |
| Sale Of Investment | $31,500,000 | $21,250,000 | $0 | - |
| Purchase Of Investment | $-18,261,000 | $-29,000,000 | $-13,699,000 | $0 |
| Net PPE Purchase And Sale | $-1,098,000 | $-381,000 | $-1,025,000 | $-49,000 |
| Purchase Of PPE | $-1,098,000 | $-381,000 | $-1,025,000 | $-49,000 |
| Change In Working Capital | $-1,046,000 | $751,000 | $-3,281,000 | $-1,691,000 |
| Change In Other Current Liabilities | $-337,000 | $-651,000 | $-523,000 | $-389,000 |
| Change In Payables And Accrued Expense | $-775,000 | $1,043,000 | $-3,071,000 | $3,196,000 |
| Change In Accrued Expense | $438,000 | $-1,113,000 | $-713,000 | $883,000 |
| Change In Payable | $-1,213,000 | $2,156,000 | $-2,358,000 | $2,313,000 |
| Change In Account Payable | $-1,213,000 | $2,156,000 | $-2,358,000 | $2,313,000 |
| Change In Prepaid Assets | $66,000 | $359,000 | $483,000 | $-168,000 |
| Other Non Cash Items | $898,000 | $1,674,000 | $1,589,000 | $-56,000 |
| Stock Based Compensation | $6,677,000 | $6,070,000 | $5,204,000 | $2,415,000 |
| Amortization Of Securities | $-226,000 | $-757,000 | $-62,000 | $0 |
| Depreciation Amortization Depletion | $574,000 | $903,000 | $1,018,000 | $968,000 |
| Depreciation And Amortization | $574,000 | $903,000 | $1,018,000 | $968,000 |
| Depreciation | $574,000 | $903,000 | $1,018,000 | $968,000 |
| Net Income From Continuing Operations | $-32,145,000 | $-29,869,000 | $-28,297,000 | $-5,207,000 |
| Repayment Of Debt | - | $0 | $-685,000 | $-130,000 |
| Issuance Of Debt | - | $0 | $900,000 | $1,100,000 |
| Interest Paid Supplemental Data | - | $0 | $72,000 | $264,000 |
| Income Tax Paid Supplemental Data | - | $0 | $0 | $0 |
| Net Issuance Payments Of Debt | - | $0 | $215,000 | $970,000 |
| Net Short Term Debt Issuance | - | $0 | $215,000 | $1,100,000 |
| Short Term Debt Payments | - | $0 | $-685,000 | $0 |
| Short Term Debt Issuance | - | $0 | $900,000 | $1,100,000 |
| Change In Interest Payable | - | $0 | $22,000 | $886,000 |
| Net Long Term Debt Issuance | - | - | $0 | $-130,000 |
| Long Term Debt Payments | - | - | $0 | $-130,000 |
| Change In Other Working Capital | - | - | $-170,000 | $-4,330,000 |
| Gain Loss On Investment Securities | - | - | $3,152,000 | - |
| Long Term Debt Issuance | - | - | - | $1,100,000 |
Fetched: 2026-06-13